Historical record - last NADAC effective date: 7/17/2024
Product Information
NICOTINE 4 MG LOZENGE is a generic product labeled by AmerisourceBergen, priced at $0.3410 per EA under NDC 46122017708. Its NADAC has been published 443 times since Feb 10, 2016.
FDA first approved this application on Jan 31, 2006.
Strength
4 mg/1
Manufacturer
AmerisourceBergenNDC
46122017708
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA077007FDA Approved
1/31/2006
On Market Since
3/19/2014
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 4 MG LOZENGE has been published 443 times since Feb 10, 2016, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3410 per EA |
|---|---|
| All-time high | $0.4244 (Oct 11, 2017) |
| All-time low | $0.3069 (Apr 17, 2024) |
| Median price | $0.3598 |
| Average price | $0.3592 |
| Largest weekly change | +17.9% (Sep 20, 2017) |
| Weeks tracked | 443 |
| Tracking since | Feb 10, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.4%
5Y
-0.3%
All
-17.1%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICOTINE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG LOZENGE, manufactured by AmerisourceBergen, is $0.3410 per EA (NDC 46122017708), effective Jul 31, 2024.
How has the price of NICOTINE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for NICOTINE 4 MG LOZENGE has declined 17.1%. It has been tracked across 443 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG LOZENGE?
Since Feb 10, 2016, the NADAC for NICOTINE 4 MG LOZENGE has ranged from a low of $0.3069 (Apr 17, 2024) to a high of $0.4244 (Oct 11, 2017), with a median of $0.3598 per EA.
Are there cheaper alternatives to NICOTINE 4 MG LOZENGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NICOTINE 4 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures NICOTINE 4 MG LOZENGE?
NICOTINE 4 MG LOZENGE (NDC 46122017708) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.